LFST LifeStance Health (LFST) Q4 FY25 earnings call
LifeStance Health delivered an exceptional Q4 and full-year FY25, exceeding all guided metrics with robust organic growth and significant margin expansion. The company achieved positive net income and record free cash flow ahead of schedule, driven by strong clinician productivity and strategic technology investments. Management is confident in continued growth and operating leverage, targeting mid-teens adjusted EBITDA margins by FY28, supported by a new EHR implementation and a recently authorized share repurchase program.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
LFST operating KPIs by quarter
| KPI | This call Dec 2025 Q4 FY25 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Employees Clinicians | 8,040We grew our net clinicians by 44 in the fourth quarter and 657 for the full year, bringing our total clinician base to 8,040, representing growth of 9% year-over-year.Source: earnings call transcript | 8,542This was achieved while at the same time adding 193 clinicians in the second quarter, bringing our total clinician base to 8,542, representing growth of 11%.Source: earnings call transcript | +6.2% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.